Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | 151 John Street BARRIE ON L4N 2L1 |
Tel: | N/A |
Website: | https://www.medipharmlabs.com |
IR: | See website |
Key People | ||
Keith Strachan President | David Pidduck Chief Executive Officer, Director | Greg Hunter Chief Financial Officer |
Business Overview |
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions. |
Financial Overview |
For the fiscal year ended 31 December 2023, Medipharm Labs Corp revenues increased 49% to C$33.1M. Net loss decreased 56% to C$13.1M. Revenues reflect Products transferred at a point in time segment increase of 62% to C$32.2M, Canada segment increase of 57% to C$23.1M, Australia segment increase from C$2.6M to C$5.4M. Lower net loss reflects ECL (recovery) on receivables decrease from C$134K (expense) to C$1.9M (income). |
Employees: | 166 as of Dec 31, 2023 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $16.50M as of Dec 31, 2023 |
Annual revenue (TTM): | $33.06M as of Dec 31, 2023 |
EBITDA (TTM): | -$17.42M as of Dec 31, 2023 |
Net annual income (TTM): | -$13.08M as of Dec 31, 2023 |
Free cash flow (TTM): | -$12.81M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 404,043,917 as of Mar 6, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |